Peter Aziz, MD
Urogynecology and Reconstructive Pelvic Surgery · Las Vegas, NVNPI 1649629015
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Caldera Medical, Inc at 25.3% of the total. Reporting peaked in 2023 at $4,565 and has fallen 76.8% since, to $1,060 in 2025.
Across 91 payments — averaging $114.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Caldera Medical, Inc$3K
- Medtronic$2K
- Axonics, Inc.$2K
- Coloplast$1K
- Intuitive Surgical$1K
- Boston Scientific$842
- plus $433 from 4 others
What the payments were for
- Travel & lodging$4,07639%
- Food & beverage$5,32551%
- Education$1,00010%
- Gifts$551%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Caldera Medical, Inc | 17 | $2,646 |
| Medtronic(2 entities) | 19 | $2,054 |
| Axonics, Inc. | 22 | $1,981 |
| Coloplast | 16 | $1,469 |
| Intuitive Surgical | 2 | $1,029 |
| Boston Scientific | 8 | $842 |
| Novartis | 3 | $350 |
| Applied Medical Resources Corporation | 2 | $50 |
| Merck | 1 | $18 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few urogynecology and reconstructive pelvic surgery providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 146 | $78,546 |
| GemtesaVibegron | 14 | $11,335 |
| Methenamine Hippurate | 119 | $6,798 |
| Estradiol | 94 | $5,749 |
| Solifenacin Succinate | 43 | $782 |
| Trospium Chloride | 17 | $710 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 25 | $558 |
| Celecoxib | 46 | $532 |
| Gabapentin | 40 | $291 |
| Ondansetron Hcl | 37 | $175 |
| Ciprofloxacin Hcl | 43 | $167 |
| Oxycodone Hcl | 50 | $145 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 40 | $144 |
| Cephalexin | 26 | $133 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Las Vegas
- Geoffrey HsiehLas Vegas$36K
- Lannah Lorraine Lua-MaillandLas Vegas$3K
- Javier GonzalezLas Vegas$126
- Richard WassermanHenderson$53K
- Angela DaoReno$2K
- Kerac FalkReno$1K
- Charu DhingraNorth Las Vegas$655
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.